SSTR2 and cancer: Additional IHC markers of NET differentiation include somatostatin receptor type 2 (SSTR2), which can also be used to infer somatostatin analogue (SSA) sensitivity and utility of SSTR functional imaging and is reduced in poorly differentiated cancers [34, 35].